May 16, 2007 — Stentys has announced that the results of preclinical testing of its bifurcated stent will be reported on Thursday, May 24, 2007, at the "EuroPCR 2007" Cardiovascular Congress in Barcelona, Spain next week as part of the "Innovative Emerging Technologies" program.
Stentys is the first company to develop the next-generation of dedicated drug-eluting stents for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery.